Is AMS Polymers Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, AMS Polymers Ltd (540066.BO) is currently classified as NOT HALAL as of March 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is AMS Polymers Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes AMS Polymers Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of AMS Polymers Ltd?

Muslim investors may consider investing in AMS Polymers Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is AMS Polymers Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of AMS Polymers Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for AMS Polymers Ltd updated?

The Shariah compliance status of AMS Polymers Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like AMS Polymers Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of AMS Polymers Ltd?

You can check the latest Shariah compliance status of AMS Polymers Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

AMS Polymers Ltd 540066.BO

₹71.79 ₹0.21 (0.29%) 1D

Last Updated: May 15, 12:00 AM·BSE

540066.BO Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 10, 2025

Report Source: 2025 3rd Quarter Report

AMS Polymers Ltd. Stock Analysis 540066.BO

India N/A Nano Cap Report: Q3, 2025

AMS Polymers Ltd. engages in the business of manufacture, fabricate, assemble, import, export, and deal in automobile parts. The company is headquartered in New Delhi, Delhi and currently employs 19 full-time employees. The company went IPO on 2016-09-15. The firm has diversified business activities and is primarily engaged in the businesses of manufacturing and trading of polyurethane (PU) chemical, sealants, epoxy and chemicals for automobile, construction chemicals, footwear, textile industries, chemical elements, compounds and byproducts thereof, including without limiting the generality of the forgoing laboratory and other scientific chemicals. The firm's product categories include PU resins, adhesives and coatings. Its PU Resins products include PU systems for footwear, polyester polyols, prepolymers, blended systems, and liquid and solid resins for molding applications. Its Adhesives can be used in flexible packaging, textile/artificial leather/polyvinyl chloride, solvent and water base adhesives, and EPDM & rubber crumb application. The firm offers primers, binders and protective coatings.

Key Statistics of AMS Polymers Ltd (540066.BO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹68.50₹72.00

Today's Open

₹72.00

Volume

131.00

P/E Ratio (TTM)

32.44

52 Week Range

₹27.05₹81.46

Market Cap

77.28M

Avg. Volume

1252.64

Dividend Yield

Financial Metrics & Statements of AMS Polymers Ltd (540066.BO)

FAQ's for AMS Polymers Ltd (540066.BO)

According to Musaffa’s Shariah screening methodology, AMS Polymers Ltd (540066.BO) is currently classified as NOT HALAL as of March 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.